At #ASCO26, Dr Marchetti presented findings showing that short-term fasting improved chemotherapy response and prolonged progression-free survival in advanced #ovariancancer. ecancer.org/en/video/129...
Could aspirin have a role in #endometrialcancer treatment? At #ASCO26, Dr Gentry reviews data suggesting that aspirin use at diagnosis was associated with improved disease-specific survival in patients with endometrial cancer. Watch the interview now: ecancer.org/en/video/129...
Could tarlatamab improve outcomes for patients with #smallcelllungcancer and #brainmetastases? At #ASCO26, Dr Mountzios reviews data showing improved intracranial PFS, OS, and brain response rates with tarlatamab compared with chemotherapy. ecancer.org/en/video/129...
New data in metastatic uveal #melanoma at #ASCO26 suggest that darovasertib + crizotinib may offer a new treatment option for patients with limited alternatives. Dr Orloff reviews findings showing improved PFS and response rates versus standard therapy. ecancer.org/en/video/129...
Why are younger adults with #GastrointestinalCancers experiencing worse outcomes? At #ASCO26, Dr Paulus highlights data showing higher rates of advanced-stage disease and significant racial disparities among patients diagnosed before age 50. Watch now ▶️ ecancer.org/en/video/129...
Could a blood-based biomarker improve relapse detection in germ cell tumours? At #ASCO26, Dr Nappi highlights data showing that circulating miR371 accurately detected recurrence in patients on active surveillance. ecancer.org/en/video/129...
New data presented at #ASCO26 by Dr McDonald suggests that GLP-1 therapies may be linked to a lower incidence of #BreastCancer in women. Watch the interview now 👇 ecancer.org/en/video/129...
7 years on, lorlatinib continues to deliver durable disease control in ALK-positive hashtag#NSCLC. At hashtag#ASCO26, Prof Tony Mok reviews data showing sustained PFS and intracranial protection, reinforcing lorlatinib as a highly effective first-line treatment option. ▶️ ecancer.org/en/video/129...
Can radiotherapy be safely reduced for selected patients with HPV-associated oropharyngeal cancer? At #ASCO26, Dr Lee indicates that FMISO PET-guided radiation de-escalation maintained excellent outcomes while reducing treatment intensity for most. ecancer.org/en/video/129...
Real-world data presented at #ASCO26 by Dr Paulus suggests that GLP-1 therapies may be linked to improved OS in cancer pts. Findings support further research into potential impact of GLP-1 agonists on cancer outcomes. Watch now ▶️ ecancer.org/en/video/129...
